alexa Questionnaire Survey On 100 Chinese Physicians For Awareness Of Hepatitis B Virus Infection In Rheumatoid Arthritis Patients
ISSN: 2161-0533

Orthopedic & Muscular System: Current Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Orthopedics & Rheumatology
July 28-30, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Lie Dai, An-Qi Liang, Ying-Qian Mo, Dong-Hui Zheng and Lang-Jing Zhu
Accepted Abstracts: Orthop Muscul Syst
DOI: 10.4172/2161-0533.S1.019
Abstract
Background: Approximate 7.2% Chinese have been suffered from chronic hepatitis B virus (HBV) infection manifesting positive HBsAg. The previous study showed the positive rate of HBsAg in Chinese Rheumatoid arthritis (RA) patients was 11.3%. Screening of HBV infection prior to immunosuppressive therapy, monitoring and antiviral prophylaxis during DMARDs treatment are recommended for HBsAg(+) RA patients by ACR 2008/2012 recommendations. However, little is known about the real-world clinical practice of Chinese physicians. Objectives: To investigate Chinese physicians? awareness of HBV infection in RA patients and to identify the important targets of education. Methods: A cross-section survey of 100 physicians who treated RA patients in daily clinic was conducted with a modified ACR questionnaire. The questionnaire was composed of demographic data and 10 questions concerning essential areas of screening HBV infection, monitoring and antiviral prophylaxis (or therapy) during immunosuppressive therapy for RA patients. Each question has 4-7 options for choice. The questionnaires with ≥8 answered items were regarded as valid for statistical analysis. Results: 1. 100 physicians were recruited for the survey and 92 questionnaires with ≥8 answered items were valid for statistical analysis. Among them, 73% were rheumatologist, 27% were non-rheumatologists including internal medicine physicians (14%), orthopedists (8%), traditional Chinese medical physicians (2%) and other specialists (3%). The mean working seniority was 11.3 years (range, 1-32) and 73% physicians were consulted more than 5 RA patients per month. 2. 23% of physicians reported no routine screening for HBV infection before immunosuppressive therapy for outpatients with RA, comparing 92% for hospitalized RA patients. During immunosuppressive therapy for HBsAg(+) RA patients, 36% physicians reported no regular monitoring of HBV DNA and 12% reported no regular monitoring of aminotransferases. Twenty-four percentage of physicians considered antiviral prophylaxis for HBsAg(+) RA patients and regarding to the detailed indications of antiviral prophylaxis, 62% (57/92) physicians considered high HBV load, 39% (36/92) considered elevated aminotransferases, and 32% (29/92) considered both HBsAg(+) and HBeAg(+). 3. 88% of physicians had clinical experience of antiviral prophylaxis or therapy for RA patients. Among them, 62% prescribed antiviral drug before or at the initiation of immunosuppressive therapy and 38% prescribed antiviral drug after HBV reactivation. Conclusions: Our results showed that Chinese physicians have poor awareness of HBV infection for RA patients. The further CME should emphasize the routine screening for HBV infection especially in RA outpatients, regular monitoring of HBV DNA for HBsAg(+) RA patients, and antiviral prophylaxis considered to all HBsAg(+) RA patients with immunosuppressive treatment.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords